日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial

辅助细胞因子诱导的杀伤细胞免疫疗法治疗肝细胞癌:一项随机对照试验的真实世界数据和9年延长随访结果

Shin, Hyunjae; Park, Youngsu; Song, Byeong Geun; Choi, Won-Mook; Han, Hyung Joon; Lee, Youngwoo; Song, Tae-Jin; Yeon, Jong-Eun; Lim, Young-Suk; Hur, Moon Haeng; Lee, Yun Bin; Cho, Eun Ju; Yu, Su Jong; Kim, Yoon Jun; Lee, Joon Hyeok; Yoon, Jung-Hwan; Lee, Jeong-Hoon

Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol

一项多中心前瞻性试验,比较使用钆塞酸的简化磁共振成像与CT在检测晚期复发性肝细胞癌方面的差异(AMRICT):研究方案

Park, Hyo Jung; Lee, Dong Ho; Chang, Won; Kim, Hae Young; Kim, Dong Hwan; Choi, Won-Mook; Chung, Sung Won; Choi, Jonggi; Lee, Danbi; Shim, Ju Hyun; Lee, Han Chu; Lim, Young-Suk; Kim, Seon-Ok; Singal, Amit G; Kim, So Yeon

Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United States

美国酒精相关性肝病中的性别差异和酒精相关癌症的亚型差异

Danpanichkul, Pojsakorn; Pang, Yanfang; Mahendru, Tanuj; Tothanarungroj, Primrose; Díaz, Luis Antonio; Arab, Juan Pablo; Jatupornpakdee, Pimtawan; Muthiah, Mark D; Duangsonk, Kwanjit; Choi, Won-Mook; Huang, Daniel Q; Kim, Donghee; Noureddin, Mazen; Wijarnpreecha, Karn; Liangpunsakul, Suthat; Singal, Amit G; Yang, Ju Dong

Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association

国际肝癌协会的一项分析:肝细胞癌患者获得全身治疗的机会存在差异

Allaire, Manon; Da Fonseca, Leonardo G; Sanduzzi-Zamparelli, Marco; Choi, Won-Mook; Monge, Cecilia; Liu, Ken; Leibfried, Michael; Manes, Sarah; Maravic, Zorana; Mishkovikj, Milan; Bruix, Jordi; Reeves, Helen L; Salem, Riad; Sangro, Bruno

Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma

与乐伐替尼相比,阿特珠单抗联合贝伐珠单抗一线系统治疗肝细胞癌会增加蛋白尿风险。

Yang, Jiwon; Choi, Won-Mook; Kim, Hyung-Don; Choi, Jonggi; Yoo, Changhoon; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu

Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma

病毒复制活性与乙型肝炎病毒相关肝细胞癌术后复发之间的关联

Heo, Subin; Yang, Jiwon; Park, Jeayeon; Hui, Rex Wan-Hin; Song, Byeong Geun; Song, In-Hye; Yoon, Young-In; Cheung, Tan-To; Chung, Sung Won; Choi, Jonggi; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Seto, Wai-Kay; Lee, Jeong-Hoon; Choi, Won-Mook

Comparison of 4 first-line endoscopic biliary drainage modalities in distal malignant biliary obstruction: A systematic review and network meta-analysis

远端恶性胆道梗阻一线内镜胆道引流方式的比较:系统评价和网络荟萃分析

Huh, Gunn; Choi, Won-Mook; Lee, Jung Bok; Vargo, John J; Jang, Sunguk; Lee, Taehyung; Park, Ce Hwan; Edmundowicz, Steven A; Park, Do Hyun

Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol

简短的钆塞酸增强磁共振成像与超声检查在肝细胞癌高危患者监测中的比较:一项随机试验方案

Park, Hyo Jung; Choi, Jonggi; Kim, Dong Wook; Choi, Sang Hyun; Choi, Won-Mook; Chung, Sung Won; Lee, Danbi; Shim, Ju Hyun; Lee, Han Chu; Lim, Young-Suk; Kim, Min-Ju; Singal, Amit G; Park, Seong Ho; Kim, So Yeon

Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study

真实世界中乐伐替尼与索拉非尼作为肝细胞癌一线治疗方案的比较:一项多中心研究

Kang, Mira; Cha, Won Chul; Sinn, Dong Hyun; Jeong, Woo Kyoung; Kim, Do Young; Lee, Min Ji; Lim, Subin; Kim, DongKyu; Kim, Kyu-Pyo; Ryoo, Baek-Yeol; Choi, Won-Mook; Kim, Kang Mo; Kim, Ki-Hun; Lee, Doik; Choi, Eui Jun; Jung, Choungwon; Kim, Joohyun; Hong, Jung Yong

Managing Complex Hepatocellular Carcinoma Subtypes: Diffuse Infiltrative, Large Tumours, and Tumour Rupture-The Challenges and Strategies

复杂肝细胞癌亚型的管理:弥漫浸润型、大肿瘤型和肿瘤破裂型——挑战与策略

Choudhury, Ashok; Roy, Akash; Mukund, Amar; Sharma, Deepti; Heo, Subin; Choi, Won-Mook